Phase 4 Tuberculosis Trial, Recruiting (NCT05493267)

Phase 4 Tuberculosis Trial, Recruiting NCT05493267 Sponsor: Shanghai Pulmonary Hospital, Shanghai, China Condition: Tuberculosis

Printed from Voxsanity (voxsanity.com.au) — NCT05493267 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Tuberculosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with tuberculosis (TB) that is resistant to at least two common TB antibiotics (isoniazid and rifampicin), known as drug-resistant TB or MDR-TB.
Your current TB treatment is not working well, you are not responding to treatment at all, or there are fewer than 4 medications in your treatment plan that are still effective against your TB.

Who may not be able to join:

You have a weakened immune system caused by another health condition, such as an immune system disorder or cancer.
A lab test shows that your immune cells do not respond well to two specific substances used in the trial (ZOL and IL-2) (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +8602165115006

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05493267

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China

Phase: Phase 4

Status: Recruiting

Condition: Tuberculosis

Trial contact: +8602165115006

More information: https://clinicaltrials.gov/study/NCT05493267

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with tuberculosis (TB) that is resistant to at least two common TB antibiotics (isoniazid and rifampicin), known as drug-resistant TB or MDR-TB.
Your current TB treatment is not working well, you are not responding to treatment at all, or there are fewer than 4 medications in your treatment plan that are still effective against your TB.

Who may not be able to join:

You have a weakened immune system caused by another health condition, such as an immune system disorder or cancer.
A lab test shows that your immune cells do not respond well to two specific substances used in the trial (ZOL and IL-2) (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China

Registry

ClinicalTrials.gov

Start date

3 August 2022

Est. completion

3 August 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Sputum smear and culture negative conversion

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov